← FDA Drug Approvals (Drugs@FDA)

BLEPH-30

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALLERGAN · Approved 1971-05-25

Drug application

FDA Application #

ANDA080028

Application type

Abbreviated New Drug Application (Generic)

Brand name

BLEPH-30

Generic name

Sulfacetamide Sodium

Active ingredients

SULFACETAMIDE SODIUM

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

ALLERGAN

First approval

1971-05-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown